Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis.
Saskia RicksEmily A KendallDavid W DowdyJilian A SacksSamuel G SchumacherNimalan ArinaminpathyPublished in: BMC medicine (2021)
Despite their imperfect sensitivity and specificity, Ag-RDTs have the potential to be simultaneously more impactful, and have a lower cost per death and infectious person-days averted, than current approaches to COVID-19 diagnostic testing.